21 CFR § 60.32 - Applicant response to petition.

---
identifier: "/us/cfr/t21/s60.32"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 60.32 - Applicant response to petition."
title_number: 21
title_name: "Food and Drugs"
section_number: "60.32"
section_name: "Applicant response to petition."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL"
part_number: "60"
part_name: "PATENT TERM RESTORATION"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 348, 355, 360e, 360j, 371, 379e; 35 U.S.C. 156; 42 U.S.C. 262."
regulatory_source: "53 FR 7305, Mar. 7, 1988, unless otherwise noted."
cfr_part: "60"
---


# 60.32 Applicant response to petition.

(a) The applicant shall file with FDA a written response to the petition no later than 30 days after the applicant's receipt of a copy of the petition.

(b) The applicant's response may present additional facts and circumstances to address the assertions in the petition, but shall be limited to the issue of whether the applicant acted with due diligence during the regulatory review period. The applicant's response may include documents that were not in the original patent extension application.

(c) If the applicant does not respond to the petition, FDA will decide the matter on the basis of the information submitted in the patent term restoration application, due diligence petition, and FDA records.